# Pivotal Life Sciences

Pivotal Life Sciences is a Private Equity based in San Francisco, United States.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** San Francisco, United States
- **Region:** North America
- **Address:** San Francisco, CA, United States
- **Founded:** 2017
- **Assets under management:** Undisclosed
- **Website:** www.pivotallifesciences.com
- **LinkedIn:** https://www.linkedin.com/company/pivotallifesciences

## Regulatory record

- **Reports private funds:** No

## About

Pivotal Life Sciences is a global healthcare investment firm and investment platform that provides capital to innovative companies developing therapeutic products and technologies to address major unmet medical needs. It invests across the life sciences ecosystem through venture capital and public equity strategies, including arms focused on North America and Europe, Greater China venture building, and publicly traded life sciences companies.

## Sectors

- Healthcare Services

## People

- Peter Bisgaard
- Rob Hopfner
- Tony Ho
- Glenn Batchelder
- Jeni Lee
- Brian Mills
- AJ Velasquez-Mao

## Questions

### How does Pivotal Life Sciences source investment opportunities?

The firm operates distinct sourcing channels for each of its three strategies. Pivotal bioVenture Partners originates company-specific and network-driven deals across North America and Europe, while the China arm partners directly with healthcare companies and research institutions in Greater China to build ventures. The public-equity arm identifies investment opportunities by screening publicly traded life sciences companies with scaling potential and clear therapeutic value propositions.

### What investment stages does Pivotal Life Sciences typically target?

The firm's venture strategies target early-stage, seed, startup, and growth-stage therapeutics companies, primarily before or around clinical proof-of-concept. The public-equity strategy provides flexibility to maintain exposure after an IPO, or to initiate new positions in public companies with significant growth runways. Pivotal also invests in expansion and later-stage private rounds when the opportunity fits its therapeutic mandate.

### Is Pivotal Life Sciences a single fund or a platform?

It is structured as a multi-strategy platform with separate venture, China venture-building, and public-equity vehicles under one brand. This architecture allows each vehicle to raise and deploy capital independently, maintain distinct geographic and stage focus, and invest without cross-vehicle constraints.

### Does Pivotal Life Sciences participate in fund commitments or only direct deals?

Based on the firm's public disclosures, Pivotal Life Sciences primarily executes direct investments and venture-building partnerships rather than acting as a fund-of-funds or LP in external venture managers.

## Related profiles

- [Pivotal Growth Partners](https://altss.com/profile/pivotal-growth-partners)
- [Pivot Capital Fund](https://altss.com/profile/pivot-capital-fund)

---

Last updated: 2026-08-11T15:07:49.000Z

Canonical page: https://altss.com/profile/pivotal-life-sciences

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology